FEB 19, 2020 8:01 AM PST

Forget complicated scans - ovarian cancer can be detected in the blood

WRITTEN BY: Tara Fernandez

Results from clinical trials performed in Melbourne, Australia have revealed the diagnostic potential of a new test for ovarian cancer. Instead of using conventional techniques like ultrasonography, magnetic resonance imaging (MRI) or tissue biopsies, this recently established method identifies the presence of malignancy by measuring the levels of specific inflammatory biosignatures in the bloodstream.

Early detection has been linked to better patient outcomes. Unfortunately, however, ovarian cancer rarely shows any symptoms until the advanced stages. Consequently, the mortality rates of ovarian cancer are staggering, ranking fourth in all cancers that cause death in women. Over half of all women diagnosed with ovarian cancer die within five years. Genetics, age, and being overweight have been linked to an elevated risk of developing this cancer.

Chief investigator of the study, Professor Magdalena Plebanski from the Royal Melbourne Institute of Technology (RMIT) recently described this simple blood test for ovarian cancer in Scientific Reports.

The test measures levels of a pro-inflammatory immune marker, interleukin 6 (IL-6), along with other cancer biomarkers in blood samples taken from patients. Upon validation in patient cohorts, the technique designed by Plebanksi and colleagues was found to have the same diagnostic accuracy as current gold standards: MRI and ultrasound imaging.

"This is especially important for women in remote or disadvantaged communities, where under-resourced hospitals may not have access to complex and expensive equipment like ultrasound machines or MRI scanners. It also means patients with benign cysts identified through imaging could potentially be spared unnecessary surgeries,” said Plebanski.

Previous studies have shown that IL-6 levels are significantly raised in patients with advanced or metastatic cancer. In pancreatic cancer patients, for example, higher IL-6 in circulation correlated strongly with poorer survival outcomes.

Plebanski and her fellow researchers are hopeful that the progress made towards a new generation of cancer diagnostics will enable ovarian cancer sufferers to be diagnosed much earlier.

"Developing tests that are simpler and more practical may help get more women to hospital for treatment more effectively, with the hope that survival rates will improve."


Sources: Technology Networks, Scientific Reports.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
MAR 24, 2020
Cardiology
Infection of The Heart
MAR 24, 2020
Infection of The Heart
Inflammation of the heart muscle can affect the hearts electrical system. This can reduce the heart's ability to pum ...
MAY 28, 2020
Clinical & Molecular DX
Pitcher Plants Inspire Kidney Stone Diagnostic
MAY 28, 2020
Pitcher Plants Inspire Kidney Stone Diagnostic
  Urine contains an abundance of dissolved salts and minerals such as calcium and uric acid. These can form crystal ...
JUN 04, 2020
Clinical & Molecular DX
Low T Cells Linked To High COVID Risk
JUN 04, 2020
Low T Cells Linked To High COVID Risk
  German scientists have found a link between immune cell counts and the risk of developing severe, potentially lif ...
JUN 18, 2020
Cancer
The Importance of Timing in the Standard Treatment of Glioma
JUN 18, 2020
The Importance of Timing in the Standard Treatment of Glioma
Glioblastomas, the most common form of brain cancer, are very aggressive and have a standard three-stage treatment. The ...
JUL 13, 2020
Neuroscience
Can COVID-19 Be Diagnosed by Vocal Patterns?
JUL 13, 2020
Can COVID-19 Be Diagnosed by Vocal Patterns?
Researchers from the Lincoln Laboratory have found early evidence that subtle changes in peoples' voices may indicat ...
JUL 30, 2020
Clinical & Molecular DX
Laser Beams Vibrate Viruses to Distinguish Them
JUL 30, 2020
Laser Beams Vibrate Viruses to Distinguish Them
  In light of the ongoing COVID-19 pandemic, the importance of rapid viral diagnostics has really hit home. Classic ...
Loading Comments...